Form4insider filings, from the source

SEC Form 4 · accession 0000899243-15-006285

WRIGHT MEDICAL GROUP INC · WMGI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
William L. Griffin Jr.
Officer — SVP GM BioMimetic Therapeutics
Period of report
Oct 1, 2015
Accepted (ET)
Oct 5, 2015 · 5:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001137861

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Oct 1, 2015D68,995—D0D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (Right to Buy)F3,F2$29.88Oct 1, 2015D100,000D—Jul 22, 2018Common Stock100,0000D
Employee Stock Option (Right to Buy)F4,F2$15.47Oct 1, 2015D11,811D—May 13, 2019Common Stock11,8110D
Employee Stock Option (Right to Buy)F5,F2$18.37Oct 1, 2015D9,886D—May 13, 2020Common Stock9,8860D
Employee Stock Option (Right to Buy)F6,F2$15.50Oct 1, 2015D12,855D—May 11, 2021Common Stock12,8550D
Employee Stock Option (Right to Buy)F7,F2$18.24Oct 1, 2015D1,975D—Apr 16, 2022Common Stock1,9750D
Employee Stock Option (Right to Buy)F8,F2$21.39Oct 1, 2015D20,067D—May 9, 2022Common Stock20,0670D
Employee Stock Option (Right to Buy)F9,F2$24.66Oct 1, 2015D19,948D—May 14, 2023Common Stock19,9480D
Employee Stock Option (Right to Buy)F10,F2$29.95Oct 1, 2015D17,594D—May 13, 2024Common Stock17,5940D

Explanation of responses